Datrix

Regulatory Filings • Sep 23, 2025

Informazione Regolamentata n. 20237-26-2025		Data/Ora Inizio Diffusione 23 Settembre 2025 10:11:10	Euronext Growth Milan
Societa'	:	DATRIX
Identificativo Informazione Regolamentata	:	210170
Utenza - referente	:	DATRIXNSS01 - GIUSEPPE VENEZIA
Tipologia	:	REGEM
Data/Ora Ricezione	:	23 Settembre 2025 10:11:10
Data/Ora Inizio Diffusione	:	23 Settembre 2025 10:11:10
Oggetto	:	Datrix_PR_Unica Project
Testo del comunicato

Vedi allegato

DATRIX LEADS THE EUROPEAN PROJECT UNICA TO INNOVATE THE FIGHT AGAINST CANCER WITH ARTIFICIAL INTELLIGENCE

THE ITALIAN GROUP AT THE LEAD OF AN INTERNATIONAL CONSORTIUM TO IMPROVE ONCOLOGY DIAGNOSIS AND PREVENTION THROUGH FEDERATED LEARNING AND MEDICAL IMAGING

THE PROJECT AIMS TO CREATE A FEDERATE NETWORK OF ONCOLOGY IMAGING DATA DERIVING FROM SCREENING PROGRAMS FOR BREAST, LUNG AND PROSTATE CANCERS. THE OBJECTIVE IS TO MAKE DIVERSIFIED AND REPRESENTATIVE DATASET AVAILABLE FROM ALL OVER EUROPE - INCLUDING GEOGRAPHICAL AREAS UNDERREPRESENTED TODAY - TO ACCELERATE THE DEVELOPMENT OF DIAGNOSTIC SOLUTIONS BASED ON ARTIFICIAL INTELLIGENCE

FINANCED UNDER THE EU4HEALTH PROGRAM, UNICA INVOLVES 16 RELEVANT PARTNERS, INCLUDING THE POLITECNICO DI MILANO, THE UNIVERSITAT POLITÈCNICA DE VALÈNCIA, THE UNIVERSITY HOSPITAL OF COLOGNE, THE UNIVERSITY OF LEIPZIG, THE ARISTOTLE UNIVERSITY OF THESSALONIKI, THE KAUNO KLINIKOS (LITHUANIA), THE WOJEWODZKI SZPITAL IN WROCLAW (POLAND), THE MARIBOR HOSPITAL (SLOVENIA) AND NUMEROUS OTHER HOSPITALS, RESEARCH CENTERS AND TECH COMPANIES THROUGHOUT EUROPE.

Milan, September 12, 2025 – Datrix, the international AI-powered ecosystem of software companies, coordinates the European project UNICA (Unified Network for International Cancer Advancement), funded under the EU4Health program, which aims to extend EUCAIM: one of the most strategic initiatives within the European Cancer Imaging Initiative to revolutionize cancer prevention, diagnosis and treatment in Europe.

With a total budget of approximately €5 million, UNICA operatesin one of the fastest-growing segments of digital transformation: AI in healthcare. Valued at tens of billions of euros today and expanding at double-digit annual growth rates, the sector is expected to become a key driver of innovation and efficiency in healthcare systems worldwide. Artificial intelligence is poised to deliver measurable improvements in quality of care, operational efficiency, and the long-term economic sustainability of healthcare.

Specifically, the project aims to create a federated network of oncological imaging data from screening programs for breast, lung and prostate cancer. The goal is to make available diversified and representative datasets from across Europe - including currently underrepresented geographical areas - to accelerate the development of AI-based diagnostic solutions.

This project represents a concrete application of the 'AI del Fare' (AI of Doing), the sustainable innovation model developed by Datrix. It reflects a key aspect of the company's daily work: the development of vertical AI solutions that generate real value, are immediately adoptable, ready for operational deployment, and capable of delivering measurable impact. "Leading UNICA confirms the central role that Datrix is assuming in the European landscape of AI applied to healthcare. Our commitment is to contribute concretely to more predictive, accessible and personalized medicine, enhancing collaboration between clinical centers of excellence, universities and technology companies", comments Fabrizio Milano d'Aragona, CEO of Datrix.

A European network for innovation in oncological diagnostics

UNICA involves 16 prominent partners, including Politecnico di Milano, Universitat Politècnica de València, the University Hospital of Cologne, University of Leipzig, Aristotle University of Thessaloniki, Kauno Klinikos (Lithuania), Wojewodzki Hospital in Wrocław (Poland), Maribor Hospital (Slovenia) and numerous other hospitals, research centers and tech companies throughout Europe.

The project involves adopting advanced AI models for medical image analysis, in full compliance with European regulations on privacy, ethics and interoperability. Clinical data, completely anonymized, will be shared securely through a federated infrastructure that promotes European digital sovereignty and the principle of "data altruism".

Michele Compare, CTO of Datrix Group, emphasizes: "The technological value of UNICA lies in creating a federated infrastructure that allows AI models to be applied to distributed clinical data without centralizing them. This approach not only ensures security and privacy compliance, but enables optimal use of AI power for more accurate and predictive analyses, benefiting research and clinical practice".

Pietro Pinoli, Associate Professor at the Department of Electronics, Information and Bioengineering at Politecnico di Milano, adds: "From a scientific perspective, UNICA represents a decisive step toward the availability of oncological datasets truly representative of European diversity. Standardizing, integrating and making this information interoperable means creating ideal conditions for developing advanced and clinically relevant algorithms, capable of improving early diagnosis and quality of care".

A European vision, a global impact

Why is it innovative? Today, most clinical data remains confined within individual hospitals, limiting the impact of scientific research. UNICA overcomes this obstacle through a "distributed analysis" network, where AI algorithms are brought to the data, without ever moving sensitive information from its place of origin. This model, fully GDPR-compliant, allows protecting patient privacy while exploiting the richness of heterogeneous datasets from different countries and contexts.

Unlike traditional approaches based on data centralization and therefore exposed to security risks, UNICA proposes a more sustainable and secure paradigm that accelerates medical research without compromising citizen protection.

The result is twofold: on one hand, researchers can rely on broader and more representative databases to better understand risk factors and prevention strategies; on the other hand, European healthcare systems have concrete tools to improve diagnostic accuracy and accelerate the adoption of innovative therapies.

"The fight against cancer is a global priority. As Datrix, we believe that Artificial Intelligence must be a concrete tool in service of public health and European competitiveness", concludes Milano d'Aragona.

About Datrix

Datrix is a Group listed on Euronext Growth Milan (ISIN code IT00054683), leading the first international ecosystem of vertical Artificial Intelligence software companies.

***

The Group is active with AI-Based solutions in 2 business areas: AI for Data Monetization (to maximize growth opportunities in the Martech, AdTech, and FinTech sectors by transforming data into tangible value) and AI for Industrial & Business Processes (to optimize the efficiency of industrial and business processes in key sectors such as energy, manufacturing, finance, logistics, and transportation).

The Datrix Group today includes the brands: Adapex, Aramix, ByTek, FinScience and Navla. Datrix is also a technology partner of over 20 universities and international research centers for important Research & Development projects (funded by the European Union and Italy) based on Artificial Intelligence algorithms in the fields of LifeScience/Health, Social Well Being, and Cybersecurity. Datrix, with headquarters in Italy, operates in Europe, the United States, and the United Arab Emirates.

More info at www.datrixgroup.com

For more information:

Investor Relations: Giuseppe Venezia, tel. +39 0276281064 - ir@datrixgroup.com Investor Relations Consultant: Francesca Cocco (Lerxi Consulting) - ir@datrixgroup.com Euronext Growth Advisor: Alantra / Stefano Bellavita, tel. +39 0263671601 - stefano.bellavita@alantra.com Marketing & Communication: Pierluigi Vacca (CMO Datrix) – pierluigi@datrixgroup.com Press Office: Dario Ferrante, mob. 3891328130 - dario@miserveunufficiostampa.com

Fine Comunicato n.20237-26-2025	Numero di Pagine: 5
---------------------------------	---------------------